Dr Nils Wilking, a clinical oncologist at the Karolinska Institute in Stockholm, said: “Our report highlights that in many countries new drugs are not reaching patients quickly enough and that this is having an adverse impact on patient survival. Where you live can determine whether you receive the best available treatment or not.
“To some extent this is determined by economic factors, but much of the variation between countries remains unexplained. In the US we have found that the survival of cancer patients is significantly related to the introduction of new oncology drugs.”
The researchers, whose report is published in the journal Annals of Oncology, found that Austria, France, Switzerland and the US were leaders in using new cancer drugs.
Flap supposes the American healthcare system is not as broken as the LEFT here and in Europe want it to be – so as to further their government run and intrusive programs/solutions.
But, what do you know, patients in the United States receive more timely care and the latest drugs. And they live.
This is a surprise?
Technorati Tags: Cancer, Socialized Medicine